Table 5.
GBS infection N (%) |
No GBS infection N (%) |
P value | |
---|---|---|---|
CP subtype | |||
Spastic unilateral | 11 (45.8) | 783 (41.5) | |
Spastic Bilateral | 9 (37.5) | 856 (45.4) | |
Dyskinetic | 2 (8.3) | 122 (6.5) | |
Ataxic | 2 (8.3) | 81 (4.3) | |
Nonclassified CP | 0 (0) | 43 (2.3) | 0.74* |
GMFCS | |||
I and II | 17 (81.0) | 1077 (68.3) | |
III | 2 (9.5) | 115 (7.3) | |
IV and V | 2 (9.5) | 384 (24.4) | 0.14** |
MACS | |||
I and II | 16 (84.2) | 973 (68.1) | |
III | 2 (10.5) | 170 (11.9) | |
IV and V | 1 (5.3) | 285 (20.0) | 0.097** |
VIKINGa | |||
I and II | 14 (70.6) | 1086 (66.8) | |
III | 2 (11.8) | 136 (8.4) | |
IV | 3 (17.6) | 400 (24.8) | 0.43** |
Epilepsy | 1 (4.2) | 82 (4.3) | 1.00*** |
Gastrostomy | 1 (4.2) | 221 (11.7) | 0.30*** |
GBS Group B Streptococcus, GMFCS gross motor function classification system, MACS Manual Ability Classification System.
*Pearson chi square.
**Linear-by-linear association.
***The unconditional z-pooled test.
aVIKING Speech scale.